Adalank

Relative (caution):

• Bipolar disorder (any phase) — dopaminergic D2 modulation may destabilize mood cycling
• Uncontrolled hypertension — community reports of mild BP elevation at higher doses
• Concurrent benzodiazepines or other GABAergic sedatives — additive effects on alertness
• Concurrent MAOI therapy — theoretical interaction via dopaminergic component
• Recent head trauma — no data; precautionary
• Sleep disorders — late-day dosing can worsen insomnia; restrict dosing to before noon if sleep is fragile

Substance interactions to avoid:

• Stimulants (amphetamines, methylphenidate) — additive dopaminergic load
• Recreational dopaminergic compounds — same concern

Stack overlaps to avoid:

• Semax, Selank, Adamax, P-21 at full simultaneous doses — Adalank already contains the Adamax + Selank pharmacophores

Adalank is supplied lyophilized in glass vials. Reconstitute with bacteriostatic water (0.9% benzyl alcohol preserved) — never with plain sterile water if the protocol expects multi-day use of the reconstituted solution.

Example reconstitution math for a 10 mg vial:

• Add 2 mL bacteriostatic water → 5 mg/mL concentration → 500 mcg per 0.1 mL (10 IU on a U-100 insulin syringe)
• Add 5 mL bacteriostatic water → 2 mg/mL concentration → 200 mcg per 0.1 mL (4 IU on a U-100 insulin syringe)

For intranasal use, dilute further to produce 100-200 mcg per spray, depending on the nasal applicator's dosing volume per actuation.

Storage:

• Lyophilized: refrigerate or freeze. Stable for 12+ months sealed.
• Reconstituted: refrigerate, use within 28 days. Do not freeze reconstituted solution.

Mixing: Swirl gently — do not shake. Peptide bonds shear under vigorous agitation. The solution should be clear after 1-2 minutes of gentle swirling. Cloudy or discolored solutions indicate degradation or contamination and should be discarded.

Adalank is itself a stack (Adamax + Selank chemistry in one molecule), so additional stacking should be done conservatively to avoid receptor-level overlap.

Reasonable pairings:

• Cerebrolysin — neurotrophic amplification. The peptide fragment mix in Cerebrolysin layers cleanly on top of Adalank's BDNF/TrkB signal without direct receptor overlap.
• Dihexa — angiotensin-IV-derived synaptogenic. Complementary mechanism (HGF signaling) rather than overlapping with the BDNF or GABA pathways Adalank already covers.
• BPC-157 — neuroprotective baseline. Pairs with cognitive enhancers via dopaminergic system stabilization. No mechanistic overlap.
• Methylene Blue — mitochondrial cofactor for general cognitive support. Different mechanism layer.

Avoid stacking with:

• Adamax — Adalank already contains the Adamax pharmacophore. Stacking is redundant and risks D2 desensitization.
• Selank — same reason: Adalank already contains the Selank pharmacophore.
• Semax, N-Acetyl Semax Amidate, P-21 — overlapping BDNF / TrkB / D2 signaling. Use one or the other.
• Benzodiazepines — additive GABAergic effects, potential for impaired alertness and inverted "alert calm" profile.

Cycle architecture:

Recommended 30-day cycles followed by 14-day washouts. Avoid chronic continuous dosing — receptor desensitization at both the BDNF/TrkB and GABAergic ends is a theoretical concern given the multi-mechanism profile, and there is no long-term safety data to draw on.

Adalank dosing follows a similar pattern to Selank and Adamax — micrograms, not milligrams. Vendor product labeling varies; double-check vial concentration before reconstitution because the hybrid molecule can be sold at concentrations between Selank (5-10 mg vials) and Adamax (2-10 mg vials).

Intranasal protocol (most common):

• Reconstitute lyophilized peptide in bacteriostatic water to a known concentration (often 100 mcg per spray when properly mixed)
• 2-4 sprays per session, once or twice daily during cycles
• Effects build over 7-10 days; subjective peak is typically reported in weeks 2-3 of a cycle

Subcutaneous protocol (less common but documented):

• 200-1200 mcg per injection, 1-2x daily
• Faster onset than intranasal but the duration of effect is similar given the hybrid molecule's claimed extended receptor binding

What to avoid:

• Late-evening dosing (the Adamax component can disrupt sleep at higher doses)
• Continuous chronic dosing without washouts (receptor desensitization is a theoretical concern given the multi-mechanism profile)
• Combining at full doses with overlapping family compounds (Semax, Selank, Adamax, P-21)

Stability: After reconstitution, store in the refrigerator and use within 28 days. Adalank should not be frozen post-reconstitution — repeated freeze-thaw cycles degrade the peptide bonds.